Myasthenia Gravis clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • ALXN1720 in Adults With Generalized Myasthenia Gravis

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the safety and efficacy of ALXN1720 for the treatment of generalized MG (gMG) in adults with autoantibodies against acetylcholine receptor (AChR).

    Orange, California and other locations

Our lead scientists for Myasthenia Gravis research studies include .

Last updated: